Diabetes associated risk for mortality increases with time among first stroke survivors - Findings from the Israeli National Stroke Registry.


Journal

Journal of diabetes and its complications
ISSN: 1873-460X
Titre abrégé: J Diabetes Complications
Pays: United States
ID NLM: 9204583

Informations de publication

Date de publication:
10 2021
Historique:
received: 22 04 2021
revised: 16 07 2021
accepted: 23 07 2021
pubmed: 5 8 2021
medline: 15 1 2022
entrez: 4 8 2021
Statut: ppublish

Résumé

Diabetes is a major risk factor for ischemic stroke and may affect post-stroke survival. Previous large scale studies of long-term post-stroke survival are limited and most of them excluded older patients from the study population. To compare the risk factors and sociodemographic characteristics between first ischemic stroke cases with and without diabetes and to assess the mortality risk associated with diabetes. Using population-based National Stroke Registry in Israel, all patients hospitalized for a first event of ischemic stroke between the years 2014-2018 were followed for all-cause mortality. Chi-square analysis was used to compare the differences in risk factors, sociodemographic profile and cumulative mortality between patients with and without diabetes. Cox proportional hazards models were used to estimate the hazard ratio for mortality in selected timeframes. Among 41,639 patients with a first event of ischemic stroke, 44.5% were previously diagnosed with diabetes. Diabetic patients were more likely to be males, members of the Arab ethnic group, with lower socioeconomic status and a higher prevalence of cardiovascular comorbidities, anemia, leukocytosis and abnormal kidney function. Diabetes was associated with a higher mortality risk in the first year and long term, but not in the first month following stroke. Diabetes-associated mortality risk interacted with time and age, was higher in younger age and increased with time. Our findings suggest that diabetes is associated with a higher prevalence of comorbidities among patients with first ischemic stroke and with a higher risk for mortality in the mid and long term, which is more profound in younger age.

Sections du résumé

BACKGROUND
Diabetes is a major risk factor for ischemic stroke and may affect post-stroke survival. Previous large scale studies of long-term post-stroke survival are limited and most of them excluded older patients from the study population.
OBJECTIVES
To compare the risk factors and sociodemographic characteristics between first ischemic stroke cases with and without diabetes and to assess the mortality risk associated with diabetes.
METHODS
Using population-based National Stroke Registry in Israel, all patients hospitalized for a first event of ischemic stroke between the years 2014-2018 were followed for all-cause mortality. Chi-square analysis was used to compare the differences in risk factors, sociodemographic profile and cumulative mortality between patients with and without diabetes. Cox proportional hazards models were used to estimate the hazard ratio for mortality in selected timeframes.
RESULTS
Among 41,639 patients with a first event of ischemic stroke, 44.5% were previously diagnosed with diabetes. Diabetic patients were more likely to be males, members of the Arab ethnic group, with lower socioeconomic status and a higher prevalence of cardiovascular comorbidities, anemia, leukocytosis and abnormal kidney function. Diabetes was associated with a higher mortality risk in the first year and long term, but not in the first month following stroke. Diabetes-associated mortality risk interacted with time and age, was higher in younger age and increased with time.
CONCLUSIONS
Our findings suggest that diabetes is associated with a higher prevalence of comorbidities among patients with first ischemic stroke and with a higher risk for mortality in the mid and long term, which is more profound in younger age.

Identifiants

pubmed: 34344621
pii: S1056-8727(21)00199-9
doi: 10.1016/j.jdiacomp.2021.107999
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107999

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Efrat Zamir (E)

Sackler Faculty of Medicine, Tel Aviv University, Israel. Electronic address: efratmendel@mail.tau.ac.il.

Carmit Libruder (C)

Israel Center for Disease Control, Israel Ministry of Health, Ramat Gan, Israel.

Havi Murad (H)

Biostatistics and Biomathematics Unit, Gertner Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel.

Yael Hershkovitz (Y)

Israel Center for Disease Control, Israel Ministry of Health, Ramat Gan, Israel.

Amit Zamir (A)

Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel, Affiliated to the Hebrew University and Hadassah School of Medicine, Jerusalem, Israel.

David Tanne (D)

Rambam Health Care Campus, Haifa, Israel; Technion Israel Institute of Technology, The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel.

Natan M Bornstein (NM)

Shaare Zedek Medical Center, Jerusalem, Israel.

Inbar Zucker (I)

Sackler Faculty of Medicine, Tel Aviv University, Israel; Israel Center for Disease Control, Israel Ministry of Health, Ramat Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH